User

iZafe Group AB (publ)

IZAFE-B.ST

Medical - Instruments & Supplies · Healthcare

Price

kr 0.41

+0.00 (+0.00%)

Market Cap

kr 167.3M

Exchange

Stockholm Stock Exchange

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Winston Score below 40. The stock fails on most of our quality checks.

iZafe Group is a Swedish healthcare technology company that makes automated medication dispensing systems. Its main product is Dosell, a connected device that helps elderly or chronically ill patients take the right medicine at the right time without needing a nurse present. The primary customers are home care providers, municipalities, and patients in the Nordic region who need help managing complex medication schedules.

The company earns revenue through a subscription model, charging recurring fees for the Dosell device and its connected software platform. iZafe operates mainly in Sweden and the broader Nordic market, and it remains a small, early-stage business with a market cap around $0.2 billion. The deeply negative margins show the company is spending far more than it earns, which is the central risk — it must grow its subscriber base significantly and reduce costs before it can reach profitability, and there is no guarantee it will get there.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+83.5% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

-61.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

↓ Declining (-100% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

1.9%ownership

Relatively low insider ownership

Cash Runway

~2 months

$7M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Strong grower

iZafe Group AB (publ) is growing revenue at 84% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

69.5%

Premium pricing power — 69.5% gross margin

Operating Margin

-242.8%

Losing money on operations — -242.8%

ROCE

-24.0%

Weak — -24.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+21.0%

Fast-growing sales (21.0% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-319.8%

Burning cash (-319.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial